30 participants
This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of BEAM-103 in Healthy Subjects
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-12-26
- Start Date:
- 2025-10-27
- Completion:
- 2026-01-29
Conditions
- Healthy Subjects
- Healthy Participant Study
Interventions
- DRUG
No Results Yet